IDIBELL on the media
An epigenetic change causes the formation of spheres of DNA and proteins that block antitumor genes
Researchers observed that genes that protect from cancer as the vitamin A receptor alter its activity in colon cancer cells by the presence of spherical structures formed by DNA (in this case expression regulatory regions of genes) and proteins called histones. “We have observed,” said the researcher Manel Esteller, “that epigenetic drugs, capable of demethylating […]
A group of professionals of the IDIBELL participates in the elaboration of the strategic plan of the institution for the coming years
The IDIBELL is preparing the strategic plan, which will guide its actions over the next few years. This is a fundamental instrument in order to be able to articulate the actions the IDIBELL will develop over the coming years and which replaces the plan realized in 2007, valid till the end of 2012. This document […]
A diabetes drug, a promising treatment for neurodegenerative disease
Researchers of the IDIBELL have shown that a drug used to control Type II diabetes can help repair the spinal cords of mice suffering from the inherited disease adrenoleukodystrophy which, untreated, leads eventually to a paralysis, a vegetative state and death. This is an important step along the road to the development of a therapy […]
We need to collaborate between different disciplines so that the benefit of music reverts on society
Bring together different researchers to promote a multidisciplinary debate focused on music with the aim to exchange opinions and to provide an information as complete as possible about its effects on the evolution of our species, as well as in the attitudes, emotions, and social behavior, has been the intention of the cycle “The music […]
Identified a key protein in maintaining the identity of B lymphocytes
Researchers of the Epigenetics and Cancer Biology Program at IDIBELL, led by researcher Maribel Parra, have identified a transcriptional repressor, histone deacetylase HDAC7, involved in the identity of B cells, the cells responsible to create antibodies in our immune system. The results of the study, published in PLoS Genetics, show that HDAC7 is expressed specifically […]
The use of more potent antithrombotic drugs is recommended in high-risk heart attack patients
The Cardiovascular Research Laboratory of the IDIBELL led by the cardiologist of the Bellvitge University Hospital José Luis Ferreiro has conducted a study on the effect of antiplatelet drugs given to high risk patients suffering from acute myocardial infaction (heart attack) in the context of the Infarction Code. The study concludes that when patients arrive […]
Manel Esteller, Rey Jaime I Prize in basic research
The director of the Cancer Epigenetics and Biology Program at IDIBELL, Professor of Genetics at the University of Barcelona and ICREA Research Professor, Manel Esteller has been awarded with the Rey Jaime I Prize in basic research in its 25th edition. The Rey Jaime I Awards Foundation celebrates its 25th anniversary with the participation of […]
Music and brain at CosmoCaixa
Next Tuesday June 4 at 7 pm on CosmoCaixa puts an end to the cycle of conferences “The music and its impact on the body and mind” with a panel discussion on the future of research in music. In the discussion will participate the cycle coordinator, the researcher of the IDIBELL and the University of […]
Carlos Macaya: ”Can our Health Systems assume these new techniques in interventional cardiology?”
By 1950, cardiovascular disease mortality was 450 per 100,000 inhabitants. The advent of new techniques, new drugs and the identification of risk factors have made this figure has been reduced by 300%. The cardiologist at Hospital Clínico San Carlos, Madrid, Carlos Macaya has reviewed the milestones of interventional cardiology on May 24 at a conference […]